Skip to content

Shattuck Labs, Inc. STTK Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$151K
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$2.18M
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$0-100%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$0-100%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
$6.01M
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$14.02M+4,735%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s stock issuance proceeds?
Shattuck Labs, Inc. (STTK) reported stock issuance proceeds of $20.56M in Q1 2026.
What is the long-term trend for Shattuck Labs, Inc.'s stock issuance proceeds?
Over 4 years (2021 to 2025), Shattuck Labs, Inc.'s stock issuance proceeds has grown at a 119.1% compound annual growth rate (CAGR), from $1.93M to $44.48M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.